Emrocef-T 1.125gm Injection
Marketer
Apikos Pharma
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Emrocef-T 1.125gm Injection
Cefixime and Tazobactam injection (1.125g) is a dual-action antibiotic used to combat a range of bacterial infections. Its mechanism involves inhibiting bacterial growth and halting infection progression. This injection must be administered solely by a qualified healthcare provider. Strict adherence to the prescribed dosage schedule is vital; completing the full course is crucial, even with symptom improvement, as premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and upset stomach. Significant worsening of any side effect necessitates immediate medical attention. Allergic reactions (such as rash, itching, swelling, or breathing difficulty) require immediate emergency care. Prior to commencing treatment, disclose all current medications and pre-existing health conditions to your doctor. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order blood tests and other diagnostic procedures to monitor the treatment's effectiveness.
Uses of Emrocef-T 1.125gm Injection
Infections caused by bacteria
Major Benefits of Emrocef-T 1.125gm Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.
Common Side effects of Emrocef-T 1.125gm Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Emrocef-T 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is not recommended.
How Emrocef-T 1.125gm Injection works:
Ceftriaxone and Tazobactum, combined as Emrocef-T 1.125gm Injection, offer targeted antibacterial action. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering bacterial growth and survival. Tazobactum's role as a beta-lactamase inhibitor counters bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Emrocef-T 1.125gm Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefuroxime 1.125-gram injection is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data in pregnant women are scarce.
Breast feedingCAUTION
The administration of Emrocef-T 1.125gm Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Cefixime injection (Emrocef-T 1.125gm) can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Emrocef-T 1.125gm Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Caution is advised when administering 1.125 gm Emrocef-T injections to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Dosage alteration for Emrocef-T 1.125 gm injections is unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Emrocef-T 1.125gm Injection :
Omit a dose of Emrocef-T 1.125gm Injection? Seek medical advice immediately.
Facts to Know About Emrocef-T 1.125gm Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Category | Agents against infection |
3,018 People bought this recently